The earnings call reflects a positive outlook due to record revenue and EBITDA, strong segment growth, and strategic product developments. However, there are challenges posed by anticipated changes in Medicare reimbursement and slower than expected clinical trial enrollments.

Company Guidance

During the MiMedx Second Quarter 2025 Conference Call, the company announced robust financial performance and raised guidance for the remainder of the year. Notably, net sales grew by 13% year-over-year to $99 million, marking the highest quarterly revenue in the company's history. The adjusted gross profit margin stood at 84%, while adjusted EBITDA reached $24 million, or 25% of net sales. MiMedx ended the quarter with $119 million in cash, reflecting a $12 million increase. Both the Wound and Surgical franchises achieved double-digit growth, with the Surgical business expanding by 15%. The company anticipates further growth, revising its full-year revenue growth outlook from high single digits to low double digits and projecting a full-year adjusted EBITDA margin above 20%. Additionally, MiMedx is preparing for upcoming Medicare reimbursement reforms slated for January 2026, which could impact the market dynamics but are expected to favor the company's competitive positioning due to its robust evidence supporting product efficacy.

Record Quarterly Revenue and EBITDA

MiMedx achieved a record quarterly revenue of $99 million, marking a 13% year-over-year growth. The company also reported the highest adjusted EBITDA in its history at $24 million, which is 25% of net sales.

Strong Growth Across Key Segments

Both the Wound and Surgical franchises reported double-digit growth, with the Surgical segment growing by 15% and contributions across the portfolio, including increased sales of HELIOGEN.

Increased Full-Year Revenue Guidance

Due to strong year-to-date performance, MiMedx raised its full-year revenue growth outlook from the high single digits to the low double digits. The full-year adjusted EBITDA margin is expected to be above 20%.

Strategic Product Development and Partnerships

The company is advancing its product pipeline with new offerings like EPIXPRESS and collaborative efforts such as the co-marketing of Vaporox Inc.'s VHT device, enhancing its wound care solutions.

MiMedx Group (MDXG) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

MDXG Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Oct 29, 2025	2025 (Q3)	0.06 / -	0.05	―	―	―
Jul 30, 2025	2025 (Q2)	0.05 / 0.06	0.12	-50.00% (-0.06)	―
Apr 30, 2025	2025 (Q1)	0.05 / 0.05	0.06	-16.67% (>-0.01)	―
Feb 26, 2025	2024 (Q4)	0.07 / 0.05	0.32	-84.38% (-0.27)	―
Oct 30, 2024	2024 (Q3)	0.04 / 0.05	0.06	-16.67% (>-0.01)	―
Jul 30, 2024	2024 (Q2)	0.07 / 0.12	0	―	―
Apr 30, 2024	2024 (Q1)	0.04 / 0.06	-0.06	200.00% (+0.12)
Feb 28, 2024	2023 (Q4)	0.07 / 0.32	-0.02	1700.00% (+0.34)	―
Oct 30, 2023	2023 (Q3)	0.05 / 0.06	-0.09	166.67% (+0.15)
Aug 01, 2023	2023 (Q2)	-0.02 / 0.00	-0.11	―	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

MDXG Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Jul 30, 2025	$6.52	$7.19	+10.28%
Apr 30, 2025	$6.88	$6.32	-8.14%
Feb 26, 2025	$8.01	$8.14	+1.62%
Oct 30, 2024	$5.69	$6.85	+20.39%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does MiMedx Group (MDXG) report earnings?

MiMedx Group (MDXG) is schdueled to report earning on Oct 29, 2025, Before Open (Not Confirmed).

What is MiMedx Group (MDXG) earnings time?

MiMedx Group (MDXG) earnings time is at Oct 29, 2025, Before Open (Not Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is MDXG EPS forecast?

MDXG EPS forecast for the fiscal quarter 2025 (Q3) is 0.06.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing